Detection of compounds that rescue Rab1-synuclein toxicity.
Recent studies implicate a disruption in Rab-mediated protein trafficking as a possible contributing factor to neurodegeneration in Parkinson's disease (PD). Misfolding of the neuronal protein alpha-synuclein (asyn) is implicated in PD. Overexpression of asyn results in cell death in a wide variety of model systems, and in several organisms, including yeast, worms, flies, and rodent primary neurons, this toxicity is suppressed by the overproduction of Rab proteins. These and other findings suggest that asyn interferes with Rab function and provide new avenues for PD drug discovery. This chapter describes two assay formats that have been used successfully to identify small molecules that rescue asyn toxicity in yeast. The 96-well format monitors rescue by optical density and is suitable for screening thousands of compounds. A second format measures viable cells by reduction of the dye alamarBlue, a readout that is compatible with 96-, 384-, and 1536-well plates allowing the screening of large libraries (>100,000 compounds). A secondary assay to eliminate mechanistically undesirable hits is also described.
Fleming
James
J
FoldRx Pharmaceuticals, Inc., Cambridge, Massachusetts, USA.
Outeiro
Tiago F
TF
Slack
Mark
M
Lindquist
Susan L
SL
Bulawa
Christine E
CE
D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical / Q000379:methods; D010300:Parkinson Disease / Q000188:drug therapy; D012441:Saccharomyces cerevisiae / Q000187:drug effects*; D051844:alpha-Synuclein / Q000633:toxicity*; D020691:rab GTP-Binding Proteins / Q000633:toxicity*
D051844:alpha-Synuclein; D020691:rab GTP-Binding Proteins